Europe 'failing to cash in on biotech innovation'
The EU is on par with the US and Asia in developing new biotechnologies but is trailing behind in market deployment, industry delegates heard at a conference in Amsterdam on Thursday. The event was intended to discuss the state of the bio-based economy.
The full text of this article is only available to subscribers and free trialists. To login,please enter your email address and subscriber access code below.